The Belgian biopharmaceutical sector at a glance

The success of Wallonia, the biopharmaceutical valley of Europe

The current health crisis has highlighted the resilience that Belgian companies have shown to accelerate research and allow the development, in record time, of multiple therapeutic solutions to counter the Covid-19 pandemic. This social responsibility is the proof of the value that an innovative biopharmaceutical industry could bring with its expertise in dealing with an epidemic.[…]

pocare-platform-img-3 (1)

Initial success for Orgenesis’ POCare Platform

Pharmaceutical companies used to be eager buyers of technology. But in recent years, biotech platforms have benefited from easier access to capital as independent entities, eliminating the need to sell. At the same time, biopharma companies large and small are realizing that building a platform is better than focusing on a single product or production[…]

Workshop PIPRA & icompanion copie

Looking back to the workshops with the BIDays Pitch Competition winners

The Brain Innovation Days hosted its first-ever Pitch Competition in January 2021. Out of 90 applications, 2 European start-ups particularly impressed the jury and the public: PIPRA, which is developing a cutting-edge AI-based pre-operative test to prevent post-operative delirium (Jury Award for Best Pitch); and icompanion, the digital companion for people with neurological conditions and their physicians (Public Award for Best Pitch).[…]

Brain Innovation Days COVID-19

Rewatch the 3rd Brain Innovation Days Digital Session

Thank you for attending the 3rd Brain Innovation Days Digital Session, Fast-tracking brain innovation in times of COVID-19 last Tuesday! We hope you enjoyed the event as much as we did and found the discussion and insight from our speakers relevant and interesting, looking at COVID-19 from a different angle and discovering potential lessons-learned to be[…]

TOP 20 Belgian Biotech Companies 2021

TOP 20 Belgian Biotech Companies 2021

Belgium and its companies at the forefront of the biotechnology industry in Europe Belgium is spearheading the European biotech industry. Meet some of the most successful cases of Belgian biotechnology companies. Belgium is one of the countries that provide the most to the biotech industry in Europe, as it has a total of more than[…]

1600335902672

OUAT! raises 500k€ with the Innovation Fund

  OUAT! recently raised 500k€ with the Innovation Fund. The capital infusion will support the further development of HakoBio and the roll out of the software to new clients. OUAT! aims to facilitate the digital transformation of the life sciences industry. In increasingly intelligent and connected factories, OUAT! enables the men and women of the biopharmaceutical industry to achieve[…]

1608194538472-square-2

Univercells raises €70 million in Series C Financing

Univercells Holding recently raises €70 million with two rounds of capital increase with new investors. The capital infusion will support the development of GMP facilities and the capacity to foster distributed manufacturing and supply of biologics. Univercells recently completed their Series C second close, bringing the total raised to €70 million. The financing, which was over-subscribed,[…]

George Soros

Univercells, beneficiary of financial support from major investors

Many large investors have already set their sights on the Walloon company Univercells. Among them stands out the American billionaire George Soros; famous financier and philanthropist at the age of 90, Adjuvant Capital; a fund linked to the Bill Gates galaxy, the federal government through SFPI, and the Walloon government through SRIW. Bill Gates, as[…]

digital_orthopaedics_ceo

Digital Orthopaedics is looking for its new CEO

Digital Orthopaedics is an innovative e-Health company providing a comprehensive Clinical Decision Support System (CDSS) for musculoskeletal pathologies, for the foot and ankle in particular. Digital Orthopaedics’ ambition is to transform the planning and execution of orthopedic surgeries and treatment with the ultimate goal of personalizing orthopedic treatments through the innovative use of ideation, modeling and 3D[…]

digital_orthopaedics_ankle_foot

Digital Orthopaedics introduced their new platform 3DOXpert

June was a busy month for Digital Orthopaedics. During a webinar co-organized with Synopsys, the company’s engineers described how they generate patient-specific digital twins; a mechanical replica of the patient’s foot, using image & motion analysis. This event was followed by Simbio-M, another virtual conference focused on new technologies in the field of biomechanics and[…]

OncoDNA-cancer-diagnostics

OncoDNA Closes Successful Series B Investment Round

GOSSELIES, BELGIUM – FEBRUARY 14TH, 2020 — OncoDNA (“OncoDNA or “the Company”), the healthcare technology company making precision medicine a reality, today announced that it has completed a €19 million ($20 million) Series B equity financing. The new funding will support rapid international growth, accelerate software development and hiring initiatives. The round was led by Vesalius Biocapital[…]

BioWin_gdv

We gave a lecture about clinical trials funding at “Anchoring Clinical Research in Belgium”

We took part in the event “Anchoring Clinical Research in Belgium” jointly organized by BioWin and flanders.bio in Brussels where we had an interesting debate on funding opportunities for biomedical research and clinical trials development in a sector where Belgium is leading globally. Thank you to Bone Therapeutics, icometrix and Ayming Belgium for sharing the stage.              […]

maxresdefault

OncoDNA is voted Deloitte FAST 50 & EY ‘Entreprise prometteuse de l’année’ 2015

The Deloitte Technology Fast 50 competition is an annual selection of the 50 fastest-growing technology companies within Belgium. The initiative is designed to encourage and promote entrepreneurial, fast-growing technology companies. On Wednesday 19th of November 2015, OncoDNA was named “Most Disruptive Innovator” in the Rising Star category. This award recognises companies that have developed a[…]